Fatal skin cancers secrete compound that can heal
July 16th, 2009 - 1:17 pm ICT by IANSSydney, July 16 (IANS) A compound produced by certain fatal skin tumours can potentially open the way for developing new cures, according to new research.
“The economic and social costs of treating skin cancer are enormous,” said Scott Byrne from the University of Sydney, who led the research.
“Identifying the tumour-derived compounds responsible for subverting the anti-tumour immune response will enable us to target them therapeutically,” he added.
“More specifically, we have shown that skin tumours escaping the immune system do so by secreting a compound called transforming growth factor (TGF)-beta.
“This will hopefully lead to novel immune-based therapies designed to make every skin tumour regress, and therefore reduce the ever increasing incidence of skin cancer.”
“Some skin cancers will spontaneously regress while others will continue to grow (which may be fatal),” said Byrne.
Scientists don’t yet understand why some tumours undergo regression and others continue to grow, but Byrne’s team has discovered that the immune system is critically involved in the recognition of tumours and their destruction, said a Sydney release.
“This is why transplant patients on immune suppressive therapy are more prone to getting skin cancers,” he noted.
These findings have been published by the Nature Publishing Group (NPG).
- Study on zebrafish paves way for new cancer treatment - Dec 15, 2010
- New research brings cancer vaccine a step closer - Nov 05, 2010
- Blocking action of protein blunts serious ill effects of high BP on heart - May 03, 2011
- Mechanism that helps brain cancer evade immune system attack discovered - Jan 16, 2010
- Scientists develop novel tumour busting technique - Dec 07, 2011
- 'Seek-and-destroy' cancer gene therapy results in 90pct success rate - Apr 22, 2010
- Targeted photodynamic therapy offers hope for skin cancer patients - Apr 12, 2011
- How stress may kill you - Dec 01, 2009
- Scientists stumble upon 'stop cancer' gene - Nov 16, 2011
- Scientists identify four anti-cancer compounds - Nov 30, 2011
- Possible biomarker to gauge Alzheimer's prognosis identified - Mar 18, 2011
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Gene behind rare skin cancer that heals itself discovered - Mar 11, 2011
- Mechanism for esophageal cancer identified - Apr 12, 2011
- How melanomas shield themselves from immune attack - Jan 13, 2010
Tags: beta, compounds, immune response, immune system, nature publishing group, regress, regression, scientists, skin cancer, skin cancers, skin tumours, suppressive therapy, transplant patients, university of sydney
